Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review

Iron deficiency is the primary cause of anaemia worldwide and is particularly common among children and adolescents. Intravenous (IV) iron therapy is recommended for paediatric patients with certain comorbidities or if oral iron treatment has been unsuccessful. IV ferric carboxymaltose (FCM) has rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksan, Aysegül, Zepp, Fred, Anand, Sangeetha, Stein, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439269/
https://www.ncbi.nlm.nih.gov/pubmed/36056175
http://dx.doi.org/10.1007/s00431-022-04582-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439269/
https://www.ncbi.nlm.nih.gov/pubmed/36056175
http://dx.doi.org/10.1007/s00431-022-04582-w

Ejemplares similares